Victor S. Pribluda

3.4k total citations · 1 hit paper
28 papers, 2.8k citations indexed

About

Victor S. Pribluda is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Victor S. Pribluda has authored 28 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Genetics and 6 papers in Cancer Research. Recurrent topics in Victor S. Pribluda's work include Estrogen and related hormone effects (7 papers), Receptor Mechanisms and Signaling (4 papers) and Pharmaceutical Economics and Policy (4 papers). Victor S. Pribluda is often cited by papers focused on Estrogen and related hormone effects (7 papers), Receptor Mechanisms and Signaling (4 papers) and Pharmaceutical Economics and Policy (4 papers). Victor S. Pribluda collaborates with scholars based in United States, Israel and Guyana. Victor S. Pribluda's co-authors include H Metzger, Glenn M. Swartz, Theresa LaVallee, Jean‐Pierre Kinet, Gisèle Alcaraz, R J Hohman, Rodolfo Quarto, Xiaoguo H. Zhan, Michelle S. Johnson and Shawn J. Green and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Victor S. Pribluda

28 papers receiving 2.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF

2003 610 citations Nicola J. Mabjeesh, Daniel Escuín et al. Cancer Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Victor S. Pribluda United States	20	1.3k	614	611	460	425	28	2.8k
F. H. Sarkar United States	29	1.7k 1.3×	962 1.6×	275 0.5×	229 0.5×	1.0k 2.4×	72	3.2k
Jiazhi Sun United States	23	2.2k 1.7×	355 0.6×	322 0.5×	260 0.6×	1.2k 2.9×	42	3.3k
Stephen Gately United States	24	2.0k 1.5×	1.2k 1.9×	178 0.3×	322 0.7×	675 1.6×	40	3.5k
Raymond Taetle United States	38	2.2k 1.7×	518 0.8×	538 0.9×	451 1.0×	1.2k 2.9×	129	4.4k
Pierre‐Marie Martin France	34	1.3k 1.0×	747 1.2×	137 0.2×	420 0.9×	796 1.9×	99	3.4k
John P. Fruehauf United States	37	2.1k 1.6×	756 1.2×	370 0.6×	152 0.3×	1.4k 3.4×	100	4.2k
Jianmin Sun China	33	1.7k 1.3×	402 0.7×	592 1.0×	229 0.5×	548 1.3×	113	3.1k
Ming‐Shyue Lee Taiwan	28	1.2k 0.9×	427 0.7×	263 0.4×	177 0.4×	405 1.0×	52	2.2k
Evette S. Radisky United States	35	2.1k 1.6×	1.2k 1.9×	332 0.5×	192 0.4×	1.4k 3.3×	86	3.8k
Donatella Del Bufalo Italy	42	3.0k 2.3×	1.0k 1.7×	650 1.1×	153 0.3×	1.4k 3.3×	133	4.7k

Countries citing papers authored by Victor S. Pribluda

Since Specialization

Citations

This map shows the geographic impact of Victor S. Pribluda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victor S. Pribluda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victor S. Pribluda more than expected).

Fields of papers citing papers by Victor S. Pribluda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victor S. Pribluda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victor S. Pribluda. The network helps show where Victor S. Pribluda may publish in the future.

Co-authorship network of co-authors of Victor S. Pribluda

This figure shows the co-authorship network connecting the top 25 collaborators of Victor S. Pribluda. A scholar is included among the top collaborators of Victor S. Pribluda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victor S. Pribluda. Victor S. Pribluda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Plumlee, Matthew, et al.. (2023). Inferring sources of substandard and falsified products in pharmaceutical supply chains. IISE Transactions. 56(3). 241–256. 1 indexed citations

Ozawa, Sachiko, et al.. (2020). Importance of medicine quality in achieving universal health coverage. PLoS ONE. 15(7). e0232966–e0232966. 25 indexed citations

Bempong, Daniel K., et al.. (2012). Quality of anti-malarials collected in the private and informal sectors in Guyana and Suriname. Malaria Journal. 11(1). 203–203. 30 indexed citations

Shah, Jamshed H., Gregory E. Agoston, Victor S. Pribluda, et al.. (2009). Synthesis of 2- and 17-substituted estrone analogs and their antiproliferative structure–activity relationships compared to 2-methoxyestradiol. Bioorganic & Medicinal Chemistry. 17(20). 7344–7352. 18 indexed citations

Agoston, Gregory E., Jamshed H. Shah, Xiaoguo H. Zhan, et al.. (2009). Synthesis, antiproliferative, and pharmacokinetic properties of 3- and 17-double-modified analogs of 2-methoxyestradiol. Bioorganic & Medicinal Chemistry Letters. 19(21). 6241–6244. 14 indexed citations

Agoston, Gregory E., Jamshed H. Shah, Theresa LaVallee, et al.. (2007). Synthesis and structure–activity relationships of 16-modified analogs of 2-methoxyestradiol. Bioorganic & Medicinal Chemistry. 15(24). 7524–7537. 20 indexed citations

LaVallee, Theresa, Glenn M. Swartz, K Völker, et al.. (2004). Structure-activity relationships of new chemical entities based on the anti-tumor and anti-angiogenic agent 2-methoxyestradiol. Cancer Research. 64. 943–943. 2 indexed citations

Mohan, Royce, Hans J. Hammers, Paola Bargagna‐Mohan, et al.. (2004). Withaferin A is a potent inhibitor of angiogenesis. Angiogenesis. 7(2). 115–122. 303 indexed citations

Ricker, Justin L., Zhong Chen, Xin Yang, et al.. (2004). 2-Methoxyestradiol Inhibits Hypoxia-Inducible Factor 1α, Tumor Growth, and Angiogenesis and Augments Paclitaxel Efficacy in Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research. 10(24). 8665–8673. 112 indexed citations

10.

Mabjeesh, Nicola J., Daniel Escuín, Theresa LaVallee, et al.. (2003). 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell. 3(4). 363–375. 610 indexed citations breakdown →

11.

Sibonga, Jean D., Sutada Lotinun, Glenda L. Evans, et al.. (2003). Dose-Response Effects of 2-Methoxyestradiol on Estrogen Target Tissues in the Ovariectomized Rat. Endocrinology. 144(3). 785–792. 47 indexed citations

12.

LaVallee, Theresa, et al.. (2002). 2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors alpha and beta.. PubMed. 62(13). 3691–7. 184 indexed citations

13.

Pribluda, Victor S., et al.. (2000). 2-Methoxyestradiol: an Endogenous Antiangiogenic and Antiproliferative Drug Candidate. Cancer and Metastasis Reviews. 19(1-2). 173–179. 217 indexed citations

14.

Pribluda, Victor S., et al.. (1997). Biochemical Evidence That the Phosphorylated Tyrosines, Serines, and Threonines on the Aggregated High Affinity Receptor for IgE Are in the Immunoreceptor Tyrosine-based Activation Motifs. Journal of Biological Chemistry. 272(17). 11185–11192. 28 indexed citations

15.

Metzger, Henry, Byron Goldstein, Ute M. Kent, et al.. (1994). Quantitative Aspects of Receptor Aggregation. Advances in experimental medicine and biology. 365. 175–183. 4 indexed citations

16.

Pribluda, Victor S., et al.. (1994). Transphosphorylation as the mechanism by which the high-affinity receptor for IgE is phosphorylated upon aggregation.. Proceedings of the National Academy of Sciences. 91(23). 11246–11250. 161 indexed citations

17.

Pribluda, Victor S. & H Metzger. (1992). Transmembrane signaling by the high-affinity IgE receptor on membrane preparations.. Proceedings of the National Academy of Sciences. 89(23). 11446–11450. 28 indexed citations

18.

Dreskin, Stephen C., Victor S. Pribluda, & H Metzger. (1989). IgE receptor-mediated hydrolysis of phosphoinositides by cytoplasts from rat basophilic leukemia cells.. The Journal of Immunology. 142(12). 4407–4415. 19 indexed citations

19.

Pribluda, Victor S. & Avner Rotman. (1982). Dynamics of membrane-cytoskeleton interactions in activated blood platelets. Biochemistry. 21(12). 2825–2832. 56 indexed citations

20.

Pribluda, Victor S., et al.. (1981). The State of Actin in Activated Human Platelets. European Journal of Biochemistry. 116(2). 293–296. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact